Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis
- PMID: 25457846
- DOI: 10.1053/j.gastro.2014.10.023
Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis
Comment on
-
Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial.Gastroenterology. 2014 Dec;147(6):1327-37.e3. doi: 10.1053/j.gastro.2014.08.031. Epub 2014 Aug 27. Gastroenterology. 2014. PMID: 25450083 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical